Company intelligence / Profile preview

Hony Capital

Beijing, China

Ownership: Private
Development stage: Other

Overview

Hony Capital is a leading Chinese private equity and investment management firm, founded in 2003 and sponsored by Legend Holdings. It focuses on buyout investments and value creation across various sectors of China's real economy, including significant investments in pharmaceutical, healthcare, and related industries. Managing over $10 billion in assets, Hony has invested in more than 100 companies globally, playing a key role in restructuring state-owned enterprises and pioneering cross-border M&A.

Industry: Investors

Partnerships

ZoomlionSimcere PharmaceuticalCSPC PharmaceuticalI-Mab Biopharma

Beyond the preview

Go deeper on Hony Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hony Capital.

Explore the full profile